News

2020 - 2021

  • Categories:History
  • Author:
  • Origin:
  • Time of issue:2021-03-09
  • Views:0

(Summary description)<h3 style="font-size:20px; font-weight:bold;">Milestones
</h3>
◆ Submitting the application for approval of the first generic drug for rare diseases.
◆ The new hypoglycemic drugentering Phase III clinical trials with exemption from Phase II clinical trials.
◆ Jiangsu CGenePharmaceuticalCo Ltd was established.

2020 - 2021

(Summary description)<h3 style="font-size:20px; font-weight:bold;">Milestones
</h3>
◆ Submitting the application for approval of the first generic drug for rare diseases.
◆ The new hypoglycemic drugentering Phase III clinical trials with exemption from Phase II clinical trials.
◆ Jiangsu CGenePharmaceuticalCo Ltd was established.

  • Categories:History
  • Author:
  • Origin:
  • Time of issue:2021-03-09
  • Views:0

Fruitful presentation

Contact Us

Add:Room 101, Bld C11, 218 Xinghu Rd,Suzhou industrial Park,China, 215123

Tel: +86-512-62956960(Recruitment)

         +86-512-62956961(marketing)

Copyright © 2022  CGeneTech (Suzhou, China) Co., Ltd.  All rights reserved.  苏ICP备2022006552号-1  Powered by 300.cn  SEO